Sniffing out breastfeeding: scientists decode Baby's nose
NCT ID NCT07616076
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how smell helps newborns find and latch onto the breast for breastfeeding. Researchers will use a special machine to track odors from mothers and babies in real time. The goal is to understand the role of scent in early bonding and feeding, which could help improve breastfeeding rates. About 364 mothers and their newborns will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 364 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2032
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Breastfeeding women who have given birth to a single newborn / who may be accompanied by their newborn
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Regarding mothers: * Individuals who have provided their consent (studies 1, 2, and 3) as well as that of their child (studies 1 and 3). * Adults. * Birth of a singleton newborn. * Breastfeeding woman (studies 1 and 2). * Absence of any infectious risk and any prior morbidity during pregnancy, childbirth, and breastfeeding (determined by medical staff). * Regarding newborns: * Absence of medical problems during pregnancy, at delivery (full-term birth: 37-42 weeks of amenorrhea, Apgar score \> 7 at 1 and 10 minutes; birth weight \> 2500 g), or during the neonatal period. Exclusion Criteria: * Regarding mothers: * Any mother with an infectious disease (HIV, hepatitis A or B) or under special medical supervision. * Mothers taking medication that may alter body odor (e.g., corticosteroids, progestins, antidepressants). * Mothers who smoke. * Mothers suffering from chronic (confirmed congenital anosmia) or acute impairments of the sense of smell (nasal congestion due to infection or allergy). * Mothers subject to legal protective measures (guardianship, conservatorship). * Mothers subject to judicial protective measures. * Regarding newborns: * Any child who experienced medical problems during pregnancy, childbirth, or the neonatal period (Apgar score \< 7 at 1, 5, and 10 minutes). * Congenital anosmia (if this information is noted in the medical record; for example, in cases of Du Morsier-Kallman syndrome).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mother who has given birth to A singleton newborn are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France